RxDoctor Payments Data

Rodolfo Morales, MD

Psychiatry · San Jose, CANPI 1821181611

Payments from drug & device makers

$2,602in general payments, 2019–2025

Across 154 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$751
  • Lundbeck LLC$362
  • Takeda Pharmaceuticals U.S.A., Inc.$235
  • Sunovion Pharmaceuticals Inc.$220
  • Otsuka America Pharmaceutical, Inc.$201
  • Vanda Pharmaceuticals Inc.$179
  • plus $654 from 11 others

What the payments were for

  • Food & beverage$2,53998%
  • Education$632%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,602 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$48,876
Medicare patients
64
Services billed
519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate19$47,068
Clozapine OdtClozapine20$17,484
Vilazodone Hcl43$6,676
Aripiprazole42$6,375
Clozapine84$6,054
Lurasidone Hcl44$4,735
ConcertaMethylphenidate Hcl11$4,228
Pimozide11$3,598
Quetiapine Fumarate167$3,061
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$1,411
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine42$1,108
Gabapentin51$881
Haloperidol Decanoate18$869
Chlorpromazine Hcl14$817
Desvenlafaxine Succinate ErDesvenlafaxine Succinate30$758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Concerta$110$51,29630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,954 psychiatry providers in California.

Other psychiatry in San Jose

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →